Skip to main content
Download PDF

Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma

Molecular Cancer volume 20, Article number: 152 (2021) Cite this article

The Original Article was published on 21 June 2017

Correction to: Mol Cancer 16, 106 (2017)

https://doi.org/10.1186/s12943-017-0669-9

Following the publication of the original paper [1], the authors found an error in Supplemental Figure 1E. The correct sphere image has been used in the updated figure presented here.

This correction does not affect the description, interpretation, or conclusions of the manuscript. The original article has been updated.

Reference

  1. Liu A, Zhu J, Wu G, et al. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma. Mol Cancer. 2017;16:106. https://doi.org/10.1186/s12943-017-0669-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Aibin Liu, Jinrong Zhu and Geyan Wu contributed equally to this work.

Authors and Affiliations

  1. Program of Cancer Research, Affiliated Guangzhou Women and Children’s Hospital, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, 74 Zhongshan Road II, Guangzhou, 510080, Guangdong, China

    Aibin Liu, Jinrong Zhu, Geyan Wu, Lixue Cao, Zhanyao Tan, Shuxia Zhang & Jun Li

  2. State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China

    Aibin Liu & Libing Song

  3. Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China

    Lili Jiang

  4. Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

    Jueheng Wu & Mengfeng Li

Authors
  1. Aibin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinrong Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Geyan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lixue Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhanyao Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuxia Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lili Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jueheng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mengfeng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Libing Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Libing Song or Jun Li.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, A., Zhu, J., Wu, G. et al. Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma. Mol Cancer 20, 152 (2021). https://doi.org/10.1186/s12943-021-01425-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-021-01425-4

Molecular Cancer

ISSN: 1476-4598